GlycoSeLect offers qualifying taxpayers the opportunity to invest in the development of tools for medical research and the biopharmaceutical industry through the Employment and Investment Incentive Scheme (EIIS).
- Qualifying Company
- Proven Technology
- Strong Management Team
- Avail of up to 40% income tax relief
- Minimum Investment €5,000
- No entry or exit fees
Contact us now to learn more about investment opportunities at GlycoSeLect.